Full Text
Third Party Participation in Early Benefit Assessment of Cancer Drugs in Germany

Abstract

Authors

U. Schmidt

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×